![](/img/cover-not-exists.png)
Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
Chiranjeevi Sandi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, Vahid Ezzatizadeh, Glenn Barnes, Steve Jones, James R. Rusche, Joel M. Gottesfeld, Mark A. PookVolume:
42
Year:
2011
Language:
english
Pages:
10
DOI:
10.1016/j.nbd.2011.02.016
File:
PDF, 1.19 MB
english, 2011